Package Leaflet: Information for the User
ACARIZAX 12 SQ-HDM Sublingual Lyophilisate
For use in adults and children (5-65 years of age)
Standardized allergen extract of house dust mites
(Dermatophagoides pteronyssinusand Dermatophagoides farinae)
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
ACARIZAX contains an allergen extract of house dust mites. It comes in a form known as sublingual lyophilisate, which is similar to a tablet, but much softer and is absorbed into the body by placing it under the tongue.
ACARIZAX is used to treat allergic rhinitis (inflammation of the nasal membranes) in adults and children (5-65 years of age) and associated allergic asthma caused by house dust mites in adults (18-65 years of age). ACARIZAX works by increasing immunological tolerance (the ability of your body to act) to house dust mites. You may need to take the treatment for 8 to 14 weeks before you notice any improvement.
Your doctor will check your allergic symptoms and perform a skin prick test and/or take a blood sample to determine if ACARIZAX is the right treatment for you.
The first dose of ACARIZAX should be taken under medical supervision. You should remain under observation for at least half an hour after taking the first dose. This is a precaution to observe your sensitivity to this medicine. It will also give you the opportunity to inform your doctor of any possible side effects you are experiencing.
ACARIZAX is prescribed by doctors specializing in the treatment of allergies.
Do not take ACARIZAX:
Warnings and precautions
Tell your doctor before you start taking ACARIZAX:
If you have asthma, you should continue using your usual asthma medication while starting treatment with ACARIZAX. Your doctor will tell you how to gradually reduce your asthma medication over time.
You should stop taking ACARIZAX and contact your doctor if you experience severe stomach burning or persistent difficulty swallowing, as these symptoms may be signs of an allergic inflammation of the esophagus.
You may expect to experience some local allergic reaction, from mild to moderate, during your treatment. However, if it is severe, talk to your doctor in case you need to take some anti-allergic medication, such as an antihistamine.
This medicine contains less than 1 mmol of sodium (23mg) per dose, i.e., it is essentially "sodium-free".
Children
Allergic rhinitis (inflammation of the nasal membranes):
ACARIZAX is not intended for use in children under 5 years of age.
Allergic asthma:
ACARIZAX is not intended for the treatment of allergic asthma in children under 18 years of age.
Taking ACARIZAX with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those that can be obtained without a prescription. If you are taking other medicines for your allergic symptoms such as antihistamines, asthma relief medications, or steroids, tell your doctor so that they can advise you on their use while being treated with ACARIZAX. If you stop taking these medicines for your allergic symptoms, you may experience more side effects from ACARIZAX.
Taking ACARIZAX with food and drinks
Do not eat or drink for 5 minutes after taking this medicine.
Pregnancy and breastfeeding
There is currently no experience with the use of ACARIZAX during pregnancy. Treatment with ACARIZAX should not be initiated during pregnancy. If you become pregnant during treatment, consult your doctor to determine if it is appropriate for you to continue with it.
There is currently no experience with the use of ACARIZAX during breastfeeding. However, no effects on the breastfed infant are expected. Consult your doctor if you can continue taking ACARIZAX during breastfeeding.
Driving and using machines
The influence of treatment with ACARIZAX on the ability to drive or use machines is negligible.
However, only you can judge whether your abilities are affected. Therefore, read all the information contained in this leaflet, especially section 4 "Possible side effects", and if in doubt, consult your doctor or pharmacist.
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.
The usual dose is one lyophilisate per day. Your doctor will tell you how long you should take ACARIZAX.
Make sure your hands are dry before touching this medicine. Take the medicine as follows:
If you take more ACARIZAX than you should
If you have taken too many lyophilisates, you may experience allergic symptoms, including local symptoms in the mouth and throat. If you experience severe symptoms, contact your doctor or hospital immediately.
If you forget to take ACARIZAX
If you forget to take a dose, take it later in the day. Do not take a double dose to make up for forgotten doses.
If you forget to take ACARIZAX for more than 7 days, you should contact your doctor before taking ACARIZAX again.
If you stop taking ACARIZAX
If you do not take this medicine as prescribed, you may not benefit from all the effects of the treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects can be an allergic reaction to the allergen being treated. Most side effects last from minutes to hours after taking the medicine and will disappear when you have been taking the treatment for 1-3 months.
The most serious side effects:
Uncommon (may affect up to 1 in 100 people):
Stop taking ACARIZAX and contact your doctor or hospital immediately if you experience any of the following symptoms:
Other possible side effects:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Throat tightness
Rare (may affect up to 1 in 1000 people):
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Side effects in children
Side effects in children are expected to be similar to side effects in adults and adolescents.
The side effects that can be expected to occur more frequently in children are:
Very common (may affect more than 1 in 10 people): swelling in the tongue or throat, mouth ulcers, mouth pain, taste alteration, stomach pain, diarrhea, nausea.
Common (may affect up to 1 in 10 people): eye inflammation
Uncommon (may affect up to 1 in 100 people): rapid swelling of the face and skin and allergic inflammation of the esophagus (eosinophilic esophagitis).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use ACARIZAX after the expiry date which is stated on the blister and on the package after EXP. The expiry date is the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of ACARIZAX
Appearance of the product and pack contents
Sublingual lyophilisate, round, white or off-white, with an engraving on one side.
Aluminum blisters, with one foldable sheet, packaged in a cardboard box. Each blister contains 10 sublingual lyophilisates.
Pack sizes: 10, 30, and 90 sublingual lyophilisates.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
ALK-Abelló A/S
Bøge Allé 6-8
DK-2970 Hørsholm
Denmark.
Manufacturer
ALK-Abelló. S.A.
C/ Miguel Fleta, 19
28037 – Madrid
Spain
You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder:
ALK-Abelló. S.A. C/ Miguel Fleta, 19 28037 – Madrid. | |
This medicine is authorized in the Member States of the European Economic Area under the following names:Belgium, Croatia, Germany, Hungary, Ireland, Luxembourg, Portugal, Romania, Slovenia, Spain: ACARIZAX. Date of last revision of this leaflet:December 2024 Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/. |
The average price of ACARIZAX 12 SQ-HDM SUBLINGUAL LYOPHILIZED in October, 2025 is around 106.84 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.